Medtronic EOPA Arterial Cannula Lawsuit Lawyers

Medtronic Recalls More Than 50,000 Arterial Cannulae After Reports of Leaks During Cardiopulmonary Bypass Procedures

FDA Class II Recall Raises Concerns About Potential Blood Loss, Organ Damage, and Other Serious Complications During Open-Heart Surgery

What Parker Waichman LLP Found

• More than 50,000 Medtronic arterial cannulae were recalled worldwide after reports of pinhole leaks.
• The FDA classified the action as a Class II recall because the defect may cause medically reversible health consequences if not addressed.
• The reported leaks may be difficult to detect during routine inspection because they become visible primarily when the cannula is flexed.
• Potential complications include blood loss, hypotension, ischemia, vessel injury, and organ dysfunction during cardiopulmonary bypass procedures.
• Patients harmed by a defective medical device may have the right to pursue compensation through a product liability lawsuit.

Medtronic has initiated a significant worldwide recall involving more than 50,000 arterial cannulae used during cardiopulmonary bypass procedures after receiving reports that certain devices may develop small pinhole leaks. The defect has raised concerns because these devices are used during some of the most complex and life-sustaining surgical procedures performed in hospitals.

The U.S. Food and Drug Administration (FDA) has classified the action as a Class II recall, indicating that continued use of the affected devices could cause temporary or medically reversible health problems or create a risk of serious medical complications if the issue is not addressed appropriately.

The recalled products are used during cardiopulmonary bypass procedures, commonly referred to as heart-lung bypass. During these operations, blood is diverted outside the patient’s body through specialized equipment that oxygenates and circulates blood while surgeons operate on the heart or major blood vessels. Every component in this system must function reliably because even minor equipment failures can quickly become medical emergencies.

According to Medtronic, more than 30 complaints involving pinhole leaks prompted the recall. The reported leaks occur within the wire-wound body of certain arterial cannulae and may not be visible during a standard visual inspection. Instead, the leaks are reportedly most noticeable only when the cannula is flexed, creating the possibility that a defective device could remain undetected until it is already being used during surgery.

Although the manufacturer has stated that no adverse patient outcomes have been confirmed, hospitals and surgical centers have been instructed to quarantine unused devices and return affected inventory. Because these products are distributed worldwide and commonly used in cardiovascular surgery, healthcare providers across multiple countries may be affected by this recall.

Understanding the Purpose of an Arterial Cannula During Cardiopulmonary Bypass

An arterial cannula is a critical medical device used during open-heart surgery and other cardiovascular procedures requiring cardiopulmonary bypass. The cannula serves as the pathway through which oxygenated blood is returned from the heart-lung machine back into the patient’s arterial circulation.

Once connected to the bypass system, the arterial cannula becomes one of the most important components of the surgical circuit. Blood continuously flows through the cannula while the patient’s heart is temporarily stopped or bypassed. Because of the high pressures involved, the device must maintain complete structural integrity throughout the procedure.

Any unexpected leak within the cannula can interfere with the controlled circulation of blood. Even relatively small defects may allow blood to escape the circuit, potentially affecting blood pressure, circulation, oxygen delivery, and overall surgical stability.

Unlike many disposable medical devices, arterial cannulae are used in highly specialized procedures where every second matters. Surgical teams rely on these products to perform exactly as intended under demanding conditions. A structural defect that becomes apparent only after the device has been positioned may require immediate corrective action during an already complex operation.

The Reported Defect: Small Pinhole Leaks That May Be Difficult to Detect

According to Medtronic, the recall was initiated after the company received more than 30 reports involving small pinhole leaks located within the wire-wound body of the affected cannulae.

One of the most concerning aspects of the reported defect is that these leaks may not be readily visible during ordinary inspection before surgery. Medtronic advised that the leaks are primarily detectable when the cannula is placed in a flexed position. This means a device could appear normal while lying straight on a surgical table but begin leaking once positioned inside the operative field.

Medical device defects that are difficult to identify before use present unique safety concerns. Surgical teams often have limited opportunities to replace equipment once a cardiopulmonary bypass procedure has begun. Discovering a leaking arterial cannula during surgery could require immediate intervention while the patient remains dependent on the heart-lung machine.

Because cardiovascular surgery involves continuous blood circulation outside the body, even relatively small leaks may affect surgical efficiency and increase the complexity of the procedure.

Potential Medical Complications Associated With the Recalled Devices

Medtronic identified several potential health risks associated with the reported leaks. These possible complications underscore why even a Class II recall involving no confirmed patient injuries deserves careful attention.

Potential complications include:

• Hypovolemia caused by blood loss from the bypass circuit
• Vessel laceration
• Vessel perforation
• Hypotension, or dangerously low blood pressure
• Ischemia resulting from inadequate blood flow to tissues
• Organ dysfunction caused by reduced circulation or oxygen delivery

Each of these complications has the potential to increase surgical complexity and may require additional interventions to stabilize the patient.

Hypovolemia can develop when circulating blood volume decreases significantly, potentially compromising blood pressure and organ perfusion.

Hypotension during cardiac surgery can reduce blood flow to vital organs, including the brain, kidneys, liver, and heart itself.

Ischemia occurs when tissues receive insufficient oxygen-rich blood. Depending on the duration and severity of reduced blood flow, ischemia may contribute to permanent organ injury.

Organ dysfunction following cardiovascular surgery may require prolonged hospitalization, additional surgeries, intensive care treatment, dialysis, ventilator support, or other life-sustaining therapies.

Although no injuries have been confirmed in connection with this recall, the potential consequences identified by Medtronic demonstrate why manufacturers closely monitor device performance after products enter the marketplace.

Why the FDA Classified This Recall as Class II

Medical device recalls are categorized by the FDA according to the level of health risk presented.

• A Class I recall involves products that could cause serious injury or death.
• A Class II recall, such as this Medtronic action, applies when use of the product may cause temporary or medically reversible health consequences or when the probability of serious injury is considered lower than a Class I recall.
• A Class III recall generally involves products that are unlikely to cause adverse health consequences but violate FDA regulations in another manner.

Although Class II recalls are considered less severe than Class I recalls, they should never be dismissed as insignificant. Many involve devices used in hospitals, operating rooms, and intensive care settings where equipment reliability is essential to patient safety.

Hospitals receiving recall notices typically review inventory immediately, remove affected products from circulation, notify appropriate clinical departments, and coordinate product returns with the manufacturer.

Which Medtronic Devices Are Included in the Recall?

The FDA recall includes more than 50,000 arterial cannulae distributed worldwide.

Affected products include:

• EOPA Elongated One-Piece Arterial Cannula BLUNT 22FR
  • Model 77422 – 290 units
  • Model 77522 – 11,720 units
• EOPA Elongated One-Piece Arterial Cannula DIL TIP 22FR
  • Model 77622 – 13,510 units
  • Model 77722 – 3,110 units
• EOPA 3D Arterial Cannula DIL TIP 22FR

• • Model 78222 – 3,621 units
• EOPA 3D Arterial Cannula 22FR
  • Model 78322 – 1,424 units

Healthcare facilities should compare inventory with the manufacturer’s recall notice to determine whether affected devices remain in stock.

What Hospitals and Healthcare Providers Should Do

Medtronic instructed customers to quarantine all unused recalled devices immediately and arrange for their return.

Healthcare organizations should also:

• Review inventory throughout all surgical departments.
• Remove recalled devices from circulation.
• Notify operating room personnel and perfusion teams.
• Verify replacement inventory before scheduled procedures.
• Follow manufacturer instructions regarding returns.

The company stated that no additional action is recommended for patients who have already undergone procedures using the recalled devices.

Even so, hospitals generally document recalled medical devices used during patient care and remain alert for any future information regarding device performance or updated FDA communications.

When a Medical Device Defect Leads to Patient Harm

Most recalled medical devices never cause patient injuries because hospitals identify and remove them before use. However, recalls occasionally occur only after defective products have already been implanted or used during medical procedures.

When a defective medical device contributes to patient injury, legal claims may involve allegations such as:

• Defective product design
• Manufacturing defects
• Failure to adequately test the device
• Failure to warn healthcare providers
• Negligence
• Breach of warranty

Medical device litigation often requires detailed investigation into engineering records, manufacturing processes, FDA submissions, complaint histories, quality-control procedures, and communications between manufacturers and regulators.

Potential damages may include:

• Additional medical expenses
• Corrective surgeries
• Extended hospitalization
• Rehabilitation costs
• Lost income
• Pain and suffering
• Permanent disability
• Wrongful death damages in fatal cases

Every medical device lawsuit depends upon the specific facts surrounding the patient’s treatment, the nature of the device failure, and the injuries sustained.

Why Medical Device Recalls Matter to Patients

Patients often assume that medical devices used during surgery have undergone extensive testing and quality assurance before reaching the operating room. While manufacturers must comply with federal regulations, recalls demonstrate that defects can still emerge after products have entered widespread clinical use.

Post-market surveillance remains an essential part of medical device safety. Manufacturers continually collect information from physicians, hospitals, distributors, and regulatory agencies regarding product performance.

When patterns of defects begin to appear, manufacturers may issue field corrections, safety communications, or recalls designed to reduce future patient risk.

Patients who undergo surgery generally have no control over which specific disposable medical devices are selected for their procedures. Instead, they rely on healthcare providers and manufacturers to ensure that those products function safely throughout treatment.

Prompt recalls help reduce future injuries, but they also highlight the importance of continued oversight throughout a product’s lifecycle.

Frequently Asked Questions About the Medtronic Arterial Cannula Recall

Does this recall mean every recalled cannula failed during surgery?

No. A recall does not mean every device is defective or that every patient experienced complications. Manufacturers issue recalls when a product defect has been identified that could increase the risk of harm. In this case, Medtronic reported receiving more than 30 complaints involving pinhole leaks and initiated a worldwide recall to prevent additional problems.

Should patients who previously underwent heart surgery be concerned?

Medtronic has stated that no additional action is recommended for patients already treated with the recalled devices. However, individuals with questions about their procedure should speak with their cardiac surgeon or healthcare provider. Medical records may identify the devices used during surgery if additional information becomes necessary.

What injuries could result if an arterial cannula leaks during surgery?

Potential complications identified by Medtronic include hypovolemia, hypotension, ischemia, vessel injury, and organ dysfunction. Depending on the circumstances, these complications could prolong surgery, increase recovery time, or contribute to additional medical problems requiring treatment.

Can a patient file a lawsuit if a recalled medical device caused injuries?

Possibly. Patients who suffered injuries allegedly caused by a defective medical device may be able to pursue a product liability claim. Whether a lawsuit is appropriate depends on factors such as the device involved, the nature of the defect, the injuries sustained, and the available medical evidence.

What compensation may be available in a medical device lawsuit?

Depending on the circumstances, compensation may include medical expenses, future treatment costs, rehabilitation, lost wages, diminished earning capacity, pain and suffering, permanent disability damages, and other losses recognized under applicable law.

Contact Parker Waichman LLP For A Free Case Review

Patients place tremendous trust in the medical devices used during open-heart surgery. When a product defect allegedly places that trust at risk, the consequences can be physically, emotionally, and financially overwhelming. If a recalled medical device contributed to serious complications, additional surgeries, prolonged hospitalization, or the loss of a loved one, legal options may be available.

Parker Waichman LLP represents individuals and families nationwide in medical device and product liability litigation. The firm offers free consultations to help determine whether a recalled medical device may have contributed to a preventable injury.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today to discuss your potential claim. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.